Condition category
Pregnancy and Childbirth
Date applied
Date assigned
Last edited
Prospectively registered
Overall trial status
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
Neonatal hypoglycaemia is the term used to describe low blood sugar levels in babies in the first few days after birth. Newborn babies with low blood sugar are usually treated with extra feedings (breast milk or formula); in some cases the baby will need to be fed a sugar solution using a drip. Treatment is carried out until the baby’s sugar levels become stable, which can take from hours to days, or even longer. In New Zealand, a new national guideline on treating neonatal hypoglycaemia using dextrose (sugar) gel has been developed. However, it is unclear who the best people are on the ward to put the new guideline in place: midwives or doctors. This is because newborns on postnatal wards are routinely cared for by midwives, while doctors are there to provide medical treatment for sick babies. The aim of this study is to see whether it is doctors or midwives that are best placed to implement a new guideline for changing clinical practice for babies on postnatal wards.

Who can participate?
New Zealand maternity hospitals with more than 50 births per year.

What does the study involve?
Participating hospitals are randomly allocated into one of two groups. Those in group 1 (intervention group) have a medical or midwifery leader appointed to implement a guideline on treating neonatal hypoglycaemia with dextrose gel. Those in group 2 (control group) continue to provide standard care on postnatal maternity wards. The change in the number of eligible hypoglycaemic babies treated with dextrose gel is compared from before the implementation of the guideline and then again three months afterwards.

What are the possible benefits and risks of participating?
Participation in the trial will help determine the most effective local leader to implement a guideline on the postnatal wards. The results will also potentially aid in the implementation of an effective neonatal treatment. There are no specific risks associated with participation in this study.

Where is the study run from?
University of Auckland (NZ)

When is the study starting and how long is it expected to run for?
May 2015 to March 2018

Who is funding the study?
Gravida: National Centre for Growth and Development (NZ)

Who is the main contact?
Dr J Alsweiler

Trial website

Contact information



Primary contact

Dr Jane Alsweiler


Contact details

University of Auckland
Private Bag 92019
New Zealand

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

Local clinical leaders to implement a national guideline in babies on postnatal wards: a cluster-randomised, blinded, controlled trial


Study hypothesis

Midwives are the most effective local leaders for implementing a guideline for use of oral dextrose gel to treat neonatal hypoglycaemia.

Ethics approval

New Zealand Northern A Health and Disabilities Ethics Committee, 19/03/2015, ref: 15/NTA/31.

Study design

Multi-centre cluster blinded randomised controlled trial

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet

Not available in web format, please use contact details to request a participant information sheet.


Neonatal hypoglycaemia


Participating hospitals will be randomised:
1. Intervention group will have a medical or midwifery leader to implement a guideline on oral dextrose gel to treat neonatal hypoglycaemia
2. Control group will deliver standard care

Intervention type



Drug names

Primary outcome measure

The change in the proportion of eligible hypoglycaemic babies, treated with dextrose gel before implementation of the dextrose gel guideline, to three months after implementation.

Secondary outcome measures

1. Proportion of eligible babies admitted to NICU for at least four hours
2. Proportion of eligible babies given formula as a treatment for hypoglycaemia during hospital admission
3. Amount of dextrose gel used in the hospital
4. Initial uptake of dextrose gel (change in proportion of eligible babies treated with dextrose gel before implementation of the guideline to one month after implementation)
5. Sustained use of dextrose gel (change in proportion of eligible babies treated with dextrose gel from one month after implementation to three months after implementation)
6. Successful treatment with oral dextrose gel on the blood test taken immediately following dextrose gel treatment
7. Adherence to the 'oral dextrose gel to treat neonatal hypoglycaemia guideline'
8. Breast feeding at discharge

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

Doctors and midwives attached to New Zealand maternity hospitals with >50 births/year where babies are at risk of neonatal hypoglycaemia (infant of a diabetic, late preterm, small or large for gestational age) are delivered, including hospitals where oral dextrose gel is currently in use.

Participant type


Age group




Target number of participants

34 hospitals and approximately 1250 babies born during the study period

Participant exclusion criteria

Hospitals in NZ without a doctor (paediatrician or general practitioner) available to provide medical treatment, or no midwifery care for newborn babies.

Recruitment start date


Recruitment end date



Countries of recruitment

New Zealand

Trial participating centre

University of Auckland
New Zealand

Sponsor information


University of Auckland

Sponsor details

Private Bag 92019
New Zealand

Sponsor type




Funder type

Research organisation

Funder name

Gravida: National Centre for Growth and Development (NZ)

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Planned publication the results of our study via a number of avenues including submitting an article to a peer-reviewed scientific journal, conference presentations and website publication.

Intention to publish date


Participant level data

Available on request

Basic results (scientific)

Publication list

Publication citations

Additional files

Editorial Notes

11/04/2017: The recruitment end date has been updated from 01/12/2015 to 31/08/2017 and the publication and dissemination plan has been added. 10/04/2017: The overall trial end date has been updated from 01/05/2016 to 31/03/2018